Fund Universe

← Fund Universe

☆Royalty Pharma Sub-Manager, LLC

CIK 0002081668 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.540
AUM ($M)
242
Positions
4
Turnover
0.26
Top-10 wt
100%
Herfindahl
0.265
History (qtrs)
3
Excess Return
-54.3%

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 5 positions · portfolio value $242M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
☆CYTK funds › CYTOKINETICS, INC HOLD Common Stock 34.5% -2.9% 83.5 980,392 +0 2 —
☆BCAX funds › ZENAS BIOPHARMA, INC. HOLD Common Stock 25.1% -2.0% 60.6 2,388,150 +0 2 —
☆KLRA funds › KAILERA THERAPEUTICS NEW Common Stock 22.4% +22.4% 54.1 2,455,357 +2,455,357 1 -54.3%
☆BHVN funds › BIOHAVEN LTD HOLD — 18.1% +3.7% 43.7 2,936,507 +0 2 —
☆BCRX funds › BIOCRYST PHARMACEUTICALS INC EXIT Common Stock 0.0% -21.2% 0.0 0 -3,846,154 0 —

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 242 4 0.26 100% 0.265 0.541 — in
2026Q1 173 4 0.05 100% 0.279 0.852 — entered
2025Q4 171 4 0.00 100% 0.272 0.000 — out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status